fluorodeoxyglucose f18 has been researched along with 3-dihydroxy-6-methyl-7-(phenylmethyl)-4-propylnaphthalene-1-carboxylic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dang, CV; de Wilde, RF; Dutta, P; Gillies, RJ; Hidalgo, M; Jain, SK; Kamphorst, JJ; Le, A; Maitra, A; Martinez, GV; Rabinowitz, JD; Rajeshkumar, NV; Yabuuchi, S | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and 3-dihydroxy-6-methyl-7-(phenylmethyl)-4-propylnaphthalene-1-carboxylic acid
| Article | Year |
|---|---|
Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Carbon-13 Magnetic Resonance Spectroscopy; Cell Proliferation; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Lactates; Male; Mice, Nude; Mutation; Naphthalenes; Pancreatic Neoplasms; Phosphoric Monoester Hydrolases; Positron-Emission Tomography; Pyruvic Acid; Reverse Transcriptase Polymerase Chain Reaction; Tumor Burden; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2015 |